Correlation Between Krebs Biochemicals and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Krebs Biochemicals and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Emcure Pharmaceuticals.

Diversification Opportunities for Krebs Biochemicals and Emcure Pharmaceuticals

-0.37

Correlation Coefficient

Krebs Biochemicals  Emcure Pharmaceuticals

Very good diversification

The 3 months correlation between Krebs and Emcure is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Emcure Pharmaceuticals

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to under-perform the Emcure Pharmaceuticals. In addition to that, Krebs Biochemicals is 3.38 times more volatile than Emcure Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about 0.12 per unit of volatility. If you would invest  137,420  in Emcure Pharmaceuticals on September 27, 2024 and sell it today you would earn a total of  4,650  from holding Emcure Pharmaceuticals or generate 3.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Emcure Pharmaceuticals

Krebs Biochemicals and

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Emcure Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Krebs Biochemicals and Emcure Pharmaceuticals

The main advantage of trading using opposite Krebs Biochemicals and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Krebs Biochemicals and and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.